Newer drug therapies for multiple sclerosis

J. L. Carter, M. Rodriguez

Research output: Contribution to journalArticlepeer-review


Multiple sclerosis (MS) is a disease of unknown etiology that is felt by many to be immunologically mediated. Corticosteroids have historically been used to treat acute exacerbations of MS and remain the treatment of choice, although new therapies for acute attacks are under development. Several immunosuppressive therapies have shown limited benefit in chronic progressive MS, and these modalities are reviewed in this article. Finally, several new drugs have shown promise in the symptomatic treatment of MS and are also reviewed.

Original languageEnglish (US)
Pages (from-to)31-43
Number of pages13
JournalDrug Therapy
Issue number3
StatePublished - Jun 20 1990

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Newer drug therapies for multiple sclerosis'. Together they form a unique fingerprint.

Cite this